Pathology of calcific aortic stenosis

Future Cardiology

Volumn 7, Issue 5, 2011, Pages 629-642

  Ladich, Elena ^a   Nakano, Masataka ^a   Carter Monroe, Naima ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

Author keywords

aortic valve replacement; calcific aortic stenosis; calcification; pathology; risk factors

Indexed keywords

CHOLESTEROL; EZETIMIBE PLUS SIMVASTATIN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOPONTIN; VASCULAR CELL ADHESION MOLECULE 1; WNT PROTEIN;

AGE; AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; BICUSPID AORTIC VALVE; BODY MASS; CALCIFICATION; CARDIOVASCULAR RISK; DIABETES MELLITUS; ECHOCARDIOGRAPHY; GENDER; GENETICS; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOKING; TRICUSPID VALVE DISEASE;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 80053104217     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.53     Document Type: Review

References (82)

1. Vaishnava P, Fuster V, Goldman M, Bonow RO. Surgery for asymptomatic degenerative aortic and mitral valve disease. Nat. Rev. Cardiol. 8(3), 173-177 (2011).
2. Roberts WC. The structure of the aortic valve in clinically isolated aortic stenosis. An autopsy study of 162 patients over 15 years of age. Circulation 42(1), 91-97 (1970).
3. Subramanian R, Olson LJ, Edwards WD. Surgical pathology of pure aortic stenosis. A study of 374 cases. Mayo Clin. Proc. 59(10), 683-690 (1984). (Pubitemid 14014354)
4. Passik CS, Ackermann DM, Pluth JR, Edwards WD. Temporal changes in the causes of aortic stenosis. A surgical pathologic study of 646 cases. Mayo Clin. Proc. 62(2), 119-123 (1987). (Pubitemid 17016453)
5. Collins MJ, Butany J, Borger MA, Strauss BH, David TE. Implications of a congenitally abnormal valve. A study of 1025 consecutively excised aortic valves. J. Clin. Pathol. 61(4), 530-536 (2008). (Pubitemid 351518240)
6. Baumgartner H, Hung J, Bermejo J et al. Echocardiographic assessment of valve stenosis. EAE/ASE recommendations for clinical practice. J. Am. Soc. Echocardiogr. 22(1), 1-23; quiz 101-102 (2009).
7. Baumgartner H, Hung J, Bermejo J et al. Echocardiographic assessment of valve stenosis. EAE/ASE recommendations for clinical practice. Eur. J. Echocardiogr. 10(1), 1-25 (2009).
8. Faggiano P, Aurigemma GP, Rusconi C, Gaasch WH. Progression of valvular aortic stenosis in adults: literature review and clinical implications. Am. Heart J. 132(2 Pt 1), 408-417 (1996). (Pubitemid 26292409)
9. Cosmi JE, Kort S, Tunick PA et al. The risk of the development of aortic stenosis in patients with "benign" aortic valve thickening. Arch. Intern. Med. 162(20), 2345-2347 (2002). (Pubitemid 35332517)
10. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: a long-term retrospective study. Eur. Heart J. 12(1), 10-14 (1991).
11. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N. Engl. J. Med. 341(3), 142-147 (1999). (Pubitemid 29325741)
12. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 78(5), 472-474 (1997). (Pubitemid 27515107)
13. Yip CY, Simmons CA. The aortic valve microenvironment and its role in calcific aortic valve disease. Cardiovasc. Pathol. 20(3), 177-182 (2011).
14. Simmons CA, Grant GR, Manduchi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ. Res. 96(7), 792-799 (2005). (Pubitemid 40559519)
15. Butany J, Collins MJ, Demellawy DE et al. Morphological and clinical findings in 247 surgically excised native aortic valves. Can. J. Cardiol. 21(9), 747-755 (2005). (Pubitemid 41136528)
16. Roberts WC, Ko JM. Weights of individual cusps in operatively-excised stenotic three-cuspid aortic valves. Am. J. Cardiol. 94(5), 681-684 (2004). (Pubitemid 39165858)
17. Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7), 870-878 (2010).
18. Roberts WC. Morphologic aspects of cardiac valve dysfunction. Am. Heart J. 123(6), 1610-1632 (1992).
19. Sabet HY, Edwards WD, Tazelaar HD, Daly RC. Congenitally bicuspid aortic valves: a surgical pathology study of 542 cases (1991 through 1996) and a literature review of 2,715 additional cases. Mayo Clin. Proc. 74(1), 14-26 (1999). (Pubitemid 29042671)
20. Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am. J. Cardiol. 53(6), 849-855 (1984). (Pubitemid 14154705)
21. Gore I, Seiwert VJ. Dissecting aneurysm of the aorta; pathological aspects; an analysis of eighty-five fatal cases. AMA Arch. Pathol. 53(2), 121-141 (1952).
22. Roberts CS, Roberts WC. Dissection of the aorta associated with congenital malformation of the aortic valve. J. Am. Coll. Cardiol. 17(3), 712-716 (1991).
23. Fedak PW, de Sa MP, Verma S et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J. Thorac. Cardiovasc. Surg. 126(3), 797-806 (2003). (Pubitemid 37151966)
24. Isner JM, Chokshi SK, DeFranco A, Braimen J, Slovenkai GA. Contrasting histoarchitecture of calcified leaflets from stenotic bicuspid versus stenotic tricuspid aortic valves. J. Am. Coll. Cardiol. 15(5), 1104-1108 (1990). (Pubitemid 20104570)
25. Stewart BF, Siscovick D, Lind BK et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J. Am. Coll. Cardiol. 29(3), 630-634 (1997). (Pubitemid 27116107)
26. Gotoh T, Kuroda T, Yamasawa M et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study).Am. J. Cardiol. 76(12), 928-932 (1995).
27. Wilmshurst PT, Stevenson RN, Griffiths H, Lord JR. A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis. Heart 78(5), 475-479 (1997). (Pubitemid 27515108)
28. Thanassoulis G, Massaro JM, Cury R et al. Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. J. Am. Coll. Cardiol. 55(22), 2491-2498 (2010).
29. Briand M, Lemieux I, Dumesnil JG et al. Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J. Am. Coll. Cardiol. 47(11), 2229-2236 (2006). (Pubitemid 43795081)
30. Pohle K, Maffert R, Ropers D et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104(16), 1927-1932 (2001). (Pubitemid 32983236)
31. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O'Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet 359(9312), 1125-1126 (2002). (Pubitemid 34270741)
32. Moura LM, Ramos SF, Zamorano JL et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J. Am. Coll. Cardiol. 49(5), 554-561 (2007). (Pubitemid 46177435)
33. Cowell SJ, Newby DE, Prescott RJ et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N. Engl. J. Med. 352(23), 2389-2397 (2005). (Pubitemid 40958435)
34. Rossebo AB, Pedersen TR, Boman K et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N. Engl. J. Med. 359(13), 1343-1356 (2008).
35. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 121(2), 306-314 (2010).
36. Ngo DT, Sverdlov AL, Willoughby SR et al. Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc. Imaging 2(8), 919-927 (2009).
37. Sarphie TG. Interactions of IgG and b-VLDL with aortic valve endothelium from hypercholesterolemic rabbits. Atherosclerosis 68(3), 199-212 (1987). (Pubitemid 17159772)
38. Sarphie TG. A cytochemical study of the surface properties of aortic and mitral valve endothelium from hypercholesterolemic rabbits. Exp. Mol. Pathol. 44(3), 281-296 (1986). (Pubitemid 16012122)
39. Sarphie TG. Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits. Atherosclerosis 54(3), 283-299 (1985). (Pubitemid 15135416)
40. Rajamannan NM, Sangiorgi G, Springett M et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J. Heart. Valve Dis. 10(3), 371-374 (2001). (Pubitemid 32454760)
41. Rajamannan NM, Subramaniam M, Springett M et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 105(22), 2660-2665 (2002). (Pubitemid 34596044)
42. Cimini M, Boughner DR, Ronald JA, Aldington L, Rogers KA. Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study. J. Heart Valve Dis. 14(3), 365-375 (2005). (Pubitemid 47050751)
43. Drolet MC, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J. Am. Coll. Cardiol. 41(7), 1211-1217 (2003). (Pubitemid 36384911)
44. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 112(9 Suppl.), I229-I234 (2005). (Pubitemid 41266679)
45. Rajamannan NM. Calcific aortic stenosis: lessons learned from experimental and clinical studies. Arterioscler. Thromb. Vasc. Biol. 29(2), 162-168 (2009).
46. Hjortnaes J, Butcher J, Figueiredo JL et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur. Heart J. 31(16), 1975-1984 (2010).
47. Browner WS, Seeley DG, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fractures Research Group. Lancet 338(8763), 355-358 (1991).
48. Uyama O, Yoshimoto Y, Yamamoto Y, KawaiA. Bone changes and carotid atherosclerosis in postmenopausal women. Stroke 28(9), 1730-1732 (1997). (Pubitemid 27391440)
49. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90(2), 844-853 (1994). (Pubitemid 24242754)
50. Mazzone A, Epistolato MC, De Caterina R et al. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J. Am. Coll. Cardiol. 43(9), 1670-1676 (2004). (Pubitemid 38561351)
51. Soini Y, Salo T, Satta J. Angiogenesis is involved in the pathogenesis of nonrheumatic aortic valve stenosis. Hum. Pathol. 34(8), 756-763 (2003). (Pubitemid 37040610)
52. Vollebergh FE, Becker AE. Minor congenital variations of cusp size in tricuspid aortic valves. Possible link with isolated aortic stenosis. Br. Heart J. 39(9), 1006-1011 (1977). (Pubitemid 8181510)
53. Mirzaie M, Meyer T, Schorn B et al. Calcification tendency of various biological aortic valves in an experimental animal model. Cardiovasc. Surg. 7(7), 735-741 (1999).
54. Bailey MT, Pillarisetti S, Xiao H, Vyavahare NR. Role of elastin in pathologic calcification of xenograft heart valves. J. Biomed. Mater. Res. A. 66(1), 93-102 (2003). (Pubitemid 37517255)
55. Dunmore-Buyze J, Boughner DR, Macris N, Vesely I. A comparison of macroscopic lipid content within porcine pulmonary and aortic valves. Implications for bioprosthetic valves. J. Thorac. Cardiovasc. Surg. 110(6), 1756-1761 (1995)
56. Proudfoot D, Shanahan CM. Biology of calcification in vascular cells: intima versus media. Herz 26(4), 245-251 (2001). (Pubitemid 32612692)
57. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 94(4), 1597-1604 (1994).
58. Kwon HM, Hong BK, Kang TS et al. Expression of osteopontin in calcified coronary atherosclerotic plaques. J. Korean Med. Sci. 15(5), 485-493 (2000).
59. O'Brien ER, Garvin MR, Stewart DK et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14(10), 1648-1656 (1994).
60. O'Brien KD, Kuusisto J, Reichenbach DD et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 92(8), 2163-2168 (1995).
61. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 103(11), 1522-1528 (2001). (Pubitemid 32226259)
62. Rajamannan NM, Subramaniam M, Rickard D et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 107(17), 2181-2184 (2003). (Pubitemid 36547209)
63. Mazzone A, Epistolato MC, Gianetti J et al. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease? Am. J. Clin. Pathol. 126(4), 494-502 (2006). (Pubitemid 44498498)
64. Avakian SD, Annicchino-Bizzacchi JM, Grinberg M, Ramires JA, Mansura AP. Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis. Clin. Genet. 60(5), 381-384 (2001). (Pubitemid 33094905)
65. Novaro GM, Sachar R, Pearce GL, Sprecher DL, Griffin BP. Association between apolipoprotein E alleles and calcific valvular heart disease. Circulation 108(15), 1804-1808 (2003). (Pubitemid 37296088)
66. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 85(6), 635-638 (2001). (Pubitemid 32973456)
67. Garg V, Muth AN, Ransom JF et al. Mutations in NOTCH1 cause aortic valve disease. Nature 437(7056), 270-274 (2005). (Pubitemid 41294491)
68. Probst V, Le Scouarnec S, Legendre A et al. Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 113(6), 856-860 (2006).
69. Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. N. Engl. J. Med. 328(18), 1289-1296 (1993). (Pubitemid 23131369)
70. Butany J, Yu W, Silver MD, David TE. Morphologic findings in explanted Hancock II porcine bioprostheses. J. Heart Valve Dis. 8(1), 4-15 (1999). (Pubitemid 29077651)
71. Kopf GS, Geha AS, Hellenbrand WE, Kleinman CS. Fate of left-sided cardiac bioprosthesis valves in children. Arch. Surg. 121(4), 488-490 (1986). (Pubitemid 16075710)
72. Fishbein MC, Levy RJ, Ferrans VJ et al. Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system. J. Thorac. Cardiovasc. Surg. 83(4), 602-609 (1982). (Pubitemid 12140900)
73. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann. Thorac. Surg. 79(3), 1072-1080 (2005). (Pubitemid 40288798)
74. Tomazic BB, Edwards WD, Schoen FJ. Physicochemical characterization of natural and bioprosthetic heart valve calcific deposits: implications for prevention. Ann. Thorac. Surg. 60(Suppl. 2), S322-S327 (1995).
75. Schoen FJ, Levy RJ. Tissue heart valves: current challenges and future research perspectives. Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, USA, 28 April-2 May 1999. J. Biomed. Mater. Res. 47(4), 439-465 (1999). (Pubitemid 29468549)
76. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am. J. Pathol. 113(2), 143-155 (1983). (Pubitemid 13023450)
77. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab. Invest. 52(5), 523-532 (1985). (Pubitemid 15065726)
78. Salgueira M, Jarava C, Alba R et al. Valvular heart calcifications in hemodialysis patients: an analysis of predisposing factors. Nefrologia 18(3), 221-226 (1998). (Pubitemid 28292719)
79. Briand M, Pibarot P, Despres JP et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 114(Suppl. 1), I512-I517 (2006). (Pubitemid 44297200)
80. Thubrikar MJ, Deck JD, Aouad J, Nolan SP. Role of mechanical stress in calcification of aortic bioprosthetic valves. J. Thorac. Cardiovasc. Surg. 86(1), 115-125 (1983). (Pubitemid 13071689)
81. Owens DS, Otto CM. Is it time for a new paradigm in calcific aortic valve disease? JACC Cardiovasc. Imaging 2(8), 928-930 (2009).
82. Farb A, Virmani R, Burk AP. Pathology of valvular heart disease. In: Valvular Heart Disease. Alpert JS, Dalen JF, Rahimtoola SH (Eds).Lippincott, Williams & Wilkins, Philadelphia, PA, USA, 16 (2000).